Article Text

Download PDFPDF

Challenges in pulmonary fibrosis · 4: Smoking-induced diffuse interstitial lung diseases
Free
  1. Athol U Wells,
  2. Andrew G Nicholson,
  3. David M Hansell
  1. Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK
  1. Correspondence to:
    Professor Athol U Wells
    Interstitial Lung Disease Unit, Royal Brompton Hospital, Emmanuel Kaye Building, Manresa Road, London SW3 6LR, UK;a.wells{at}rbh.nthames.nhs.uk

Abstract

Smoking-induced diffuse interstitial lung processes include respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease (RBILD), desquamative interstitial pneumonia (DIP) and Langerhans’ cell histiocytosis. The histological, radiological and clinical features of respiratory bronchiolitis, RBILD and DIP are reviewed, with particular reference to management issues; Langerhans’ cell histiocytosis is covered elsewhere in this series of articles. Possible relationships between smoking and other diffuse lung diseases are explored briefly.

  • BAL, bronchoalveolar lavage
  • DIP, desquamative interstitial pneumonia
  • HRCT, high resolution computed tomography
  • IPF, idiopathic pulmonary fibrosis
  • NSIP, non-specific interstitial pneumonia
  • RBILD, respiratory bronchiolitis-associated interstitial lung disease
  • Tlco, carbon monoxide transfer factor
  • UIP, usual interstitial pneumonia
View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.